Filing Details

Accession Number:
0001493152-20-016097
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-17 16:30:30
Reporting Period:
2020-08-13
Accepted Time:
2020-08-17 16:30:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
868278 Prophase Labs Inc. PRPH Pharmaceutical Preparations (2834) 232577138
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1164762 Md Louis Gleckel 621 N. Shady Retreat Road
Doylestown, PA 18901
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0005 Acquisiton 2020-08-13 50,000 $2.75 273,840 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares were purchased in a private transaction from Ted Karkus, Chairman and Chief Executive Officer of the Issuer, pursuant to the terms of a Stock Purchase Agreement